278 related articles for article (PubMed ID: 26041746)
21. Prognostic role of tissue transglutaminase 2 in colon carcinoma.
Fernández-Aceñero MJ; Torres S; Garcia-Palmero I; Díaz Del Arco C; Casal JI
Virchows Arch; 2016 Dec; 469(6):611-619. PubMed ID: 27620315
[TBL] [Abstract][Full Text] [Related]
22. Tissue Tranglutaminase Regulates Interactions between Ovarian Cancer Stem Cells and the Tumor Niche.
Condello S; Sima L; Ivan C; Cardenas H; Schiltz G; Mishra RK; Matei D
Cancer Res; 2018 Jun; 78(11):2990-3001. PubMed ID: 29510995
[TBL] [Abstract][Full Text] [Related]
23. Image-Based Profiling of Patient-Derived Pancreatic Tumor-Stromal Cell Interactions Within a Micropatterned Tumor Model.
Mukundan S; Sharma K; Honselmann K; Singleton A; Liss A; Parekkadan B
Technol Cancer Res Treat; 2018 Jan; 17():1533033818803632. PubMed ID: 30348057
[TBL] [Abstract][Full Text] [Related]
24. The role of tissue transglutaminase (TG2) in regulating the tumour progression of the mouse colon carcinoma CT26.
Kotsakis P; Wang Z; Collighan RJ; Griffin M
Amino Acids; 2011 Oct; 41(4):909-21. PubMed ID: 21046178
[TBL] [Abstract][Full Text] [Related]
25. MTA1 coregulation of transglutaminase 2 expression and function during inflammatory response.
Ghanta KS; Pakala SB; Reddy SD; Li DQ; Nair SS; Kumar R
J Biol Chem; 2011 Mar; 286(9):7132-8. PubMed ID: 21156794
[TBL] [Abstract][Full Text] [Related]
26. Calpain inhibitor calpeptin suppresses pancreatic cancer by disrupting cancer-stromal interactions in a mouse xenograft model.
Yoshida M; Miyasaka Y; Ohuchida K; Okumura T; Zheng B; Torata N; Fujita H; Nabae T; Manabe T; Shimamoto M; Ohtsuka T; Mizumoto K; Nakamura M
Cancer Sci; 2016 Oct; 107(10):1443-1452. PubMed ID: 27487486
[TBL] [Abstract][Full Text] [Related]
27. CHIP-mediated degradation of transglutaminase 2 negatively regulates tumor growth and angiogenesis in renal cancer.
Min B; Park H; Lee S; Li Y; Choi JM; Lee JY; Kim J; Choi YD; Kwon YG; Lee HW; Bae SC; Yun CO; Chung KC
Oncogene; 2016 Jul; 35(28):3718-28. PubMed ID: 26568304
[TBL] [Abstract][Full Text] [Related]
28. Stromal SLIT2 impacts on pancreatic cancer-associated neural remodeling.
Secq V; Leca J; Bressy C; Guillaumond F; Skrobuk P; Nigri J; Lac S; Lavaut MN; Bui TT; Thakur AK; Callizot N; Steinschneider R; Berthezene P; Dusetti N; Ouaissi M; Moutardier V; Calvo E; Bousquet C; Garcia S; Bidaut G; Vasseur S; Iovanna JL; Tomasini R
Cell Death Dis; 2015 Jan; 6(1):e1592. PubMed ID: 25590802
[TBL] [Abstract][Full Text] [Related]
29. Gα(h)/transglutaminase-2 activity is required for maximal activation of adenylylcyclase 8 in human and rat glioma cells.
Obara Y; Yanagihata Y; Abe T; Dafik L; Ishii K; Nakahata N
Cell Signal; 2013 Mar; 25(3):589-97. PubMed ID: 23200849
[TBL] [Abstract][Full Text] [Related]
30. SOCS1 inhibits migration and invasion of prostate cancer cells, attenuates tumor growth and modulates the tumor stroma.
Villalobos-Hernandez A; Bobbala D; Kandhi R; Khan MG; Mayhue M; Dubois CM; Ferbeyre G; Saucier C; Ramanathan S; Ilangumaran S
Prostate Cancer Prostatic Dis; 2017 Mar; 20(1):36-47. PubMed ID: 27779203
[TBL] [Abstract][Full Text] [Related]
31. Tissue transglutaminase-induced alterations in extracellular matrix inhibit tumor invasion.
Mangala LS; Arun B; Sahin AA; Mehta K
Mol Cancer; 2005 Sep; 4():33. PubMed ID: 16153302
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of tissue transglutaminase in drug resistant and metastatic breast cancer.
Mehta K; Fok J; Miller FR; Koul D; Sahin AA
Clin Cancer Res; 2004 Dec; 10(23):8068-76. PubMed ID: 15585642
[TBL] [Abstract][Full Text] [Related]
33. Transglutaminase 2 regulates mallory body inclusion formation and injury-associated liver enlargement.
Strnad P; Harada M; Siegel M; Terkeltaub RA; Graham RM; Khosla C; Omary MB
Gastroenterology; 2007 Apr; 132(4):1515-26. PubMed ID: 17408647
[TBL] [Abstract][Full Text] [Related]
34. Imbalance of desmoplastic stromal cell numbers drives aggressive cancer processes.
Kadaba R; Birke H; Wang J; Hooper S; Andl CD; Di Maggio F; Soylu E; Ghallab M; Bor D; Froeling FE; Bhattacharya S; Rustgi AK; Sahai E; Chelala C; Sasieni P; Kocher HM
J Pathol; 2013 May; 230(1):107-17. PubMed ID: 23359139
[TBL] [Abstract][Full Text] [Related]
35. Tissue transglutaminase-mediated chemoresistance in cancer cells.
Verma A; Mehta K
Drug Resist Updat; 2007; 10(4-5):144-51. PubMed ID: 17662645
[TBL] [Abstract][Full Text] [Related]
36. Transglutaminase Interaction with α6/β4-Integrin Stimulates YAP1-Dependent ΔNp63α Stabilization and Leads to Enhanced Cancer Stem Cell Survival and Tumor Formation.
Fisher ML; Kerr C; Adhikary G; Grun D; Xu W; Keillor JW; Eckert RL
Cancer Res; 2016 Dec; 76(24):7265-7276. PubMed ID: 27780825
[TBL] [Abstract][Full Text] [Related]
37. Generation of an in vitro 3D PDAC stroma rich spheroid model.
Ware MJ; Keshishian V; Law JJ; Ho JC; Favela CA; Rees P; Smith B; Mohammad S; Hwang RF; Rajapakshe K; Coarfa C; Huang S; Edwards DP; Corr SJ; Godin B; Curley SA
Biomaterials; 2016 Nov; 108():129-42. PubMed ID: 27627810
[TBL] [Abstract][Full Text] [Related]
38. Suppression of CD51 in pancreatic stellate cells inhibits tumor growth by reducing stroma and altering tumor-stromal interaction in pancreatic cancer.
Horioka K; Ohuchida K; Sada M; Zheng B; Moriyama T; Fujita H; Manabe T; Ohtsuka T; Shimamoto M; Miyazaki T; Mizumoto K; Oda Y; Nakamura M
Int J Oncol; 2016 Apr; 48(4):1499-508. PubMed ID: 26846197
[TBL] [Abstract][Full Text] [Related]
39. Galectin-3 Mediates Tumor Cell-Stroma Interactions by Activating Pancreatic Stellate Cells to Produce Cytokines via Integrin Signaling.
Zhao W; Ajani JA; Sushovan G; Ochi N; Hwang R; Hafley M; Johnson RL; Bresalier RS; Logsdon CD; Zhang Z; Song S
Gastroenterology; 2018 Apr; 154(5):1524-1537.e6. PubMed ID: 29274868
[TBL] [Abstract][Full Text] [Related]
40. Transglutaminase Is Required for Epidermal Squamous Cell Carcinoma Stem Cell Survival.
Fisher ML; Keillor JW; Xu W; Eckert RL; Kerr C
Mol Cancer Res; 2015 Jul; 13(7):1083-94. PubMed ID: 25934691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
